[1] Zeng Q,Wang K,Zhao Y,et al. Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification[J]. Biomolecules,2023,13(3):417.[2] Martire S,Nguyen J,Sundaresan A,et al. Differential contribution of p300 and CBP to regulatory element acetylation in mESCs[J]. BMC Mol Cell Biol,2020,21(1):55.
[3] 王艳哲,吴明,叶朝阳. p300/CBP在肾脏纤维化的作用和机制[J]. 肾脏病与透析肾移植杂志,2022,31(05):461-464,500.
[4] Ghosh AK. p300 in Cardiac Development and Accelerated Cardiac Aging[J]. Aging Dis,2020,11(4):916-926.
[5] Chen Q,Yang B,Liu X,et al. Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents[J]. Theranostics,2022,12(11): 4935-4948.
[6] Kikuchi M,Morita S,Wakamori M,et al. Epigenetic mechanisms to propagate histone acetylation by p300/CBP[J]. Nat Commun,2023,14(1):4103.
[7] Yu D,Liang Y,Kim C,et al. Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma[J]. Nat Commun,2023,14(1):378.
[8] Ghosh AK. Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease[J]. Cells,2021,10(11):2839.
[9] Svensson K,Labarge SA,Sathe A,et al. p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis,contractile function,and survival[J]. J Cachexia Sarcopenia Muscle,2020,11(2):464-477.
[10] Wang J,Zhou Z. Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells[J]. Discover Discov Oncol,2023,14(1):28.
[11] Di Pietrantonio N,Di Tomo P,Mandatori D,et al. Diabetes and its cardiovascular complications:potential role of the acetyltransferase p300[J]. Cells,2023,12(3):431.
[12] Cheng Q,He F,Zhao W,et al. Histone acetylation regulates ORMDL3 expression-mediated NLRP3 inflammasome overexpression during RSV-allergic exacerbation mice[J]. J Cell Physiol,2023,238(12):2904-2923.
[13] Kumari R,Jat P. Mechanisms of cellular senescence:cell cycle arrest and senescence associated secretory phenotype[J]. Front Cell Dev Biol,2021,9:645593.
[14] Dees C,P?ter S,Zhang Y,et al. TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis[J]. J Clin Invest,2020,130(5):2347-2363.
[15] Ma J,Sanchez-Duffhues G,Goumans MJ,et al. TGF-β-induced endothelial to mesenchymal transition in disease and tissue engineering[J]. Front Cell Dev Biol,2020,8:260.
[16] Wang Y,Tu K,Liu D,et al. p300 Acetyltransferase is a cytoplasm-to-nucleus shuttle for SMAD2/3 and TAZ nuclear transport in transforming growth factor β-stimulated hepatic stellate cells[J]. Hepatology,2019,70(4):1409-1423.
[17] Rubio K,Molina-Herrera A,Pérez-González A,et al. EP300 as a molecular integrator of fibrotic transcriptional programs[J]. Int J Mol Sci,2023,24(15):12302.
[18] Hastings MH,Castro C,Freeman R,et al. Intrinsic and extrinsic contributors to the cardiac benefits of exercise[J]. JACC Basic Transl Sci,2024,9(4):535-552.
[19] Sawalha K,Norgard N,López-Candales A. Epigenetic regulation and its effects on aging and cardiovascular disease[J]. Cureus,2023,15(5):e39395.
[20] Shimizu S,Sunagawa Y,Hajika N,et al. Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response[J]. Int J Biol Sci,2022,18(3):1079-1095.
[21] Han Y,Nie J,Wang DW,et al. Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors[J]. Front Cardiovasc Med,2022,9:931475.
[22] Li X,Liu L,Li T,et al. SIRT6 in senescence and aging-related cardiovascular diseases[J]. Front Cell Dev Biol,2021,9:641315.
[23] Mao Y,Fu Q,Su F,et al. Trends in worldwide research on cardiac fibrosis over the period 1989-2022:a bibliometric study[J]. Front Cardiovasc Med,2023,10:1182606.
[24] Mehdizadeh M,Naud P,Abu-Taha IH,et al. The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology[J]. Cardiovasc Res,2024,120(5):506-518.
[25] Cunha PS,Laranjo S,Heijman J,et al. The atrium in atrial fibrillation—A clinical review on how to manage atrial fibrotic substrates[J]. Front Cardiovasc Med,2022,9:879984.
[26] Gao XY,Lai YY,Luo XS,et al. Acetyltransferase p300 regulates atrial fibroblast senescence and age-related atrial fibrosis through p53/Smad3 axis[J]. Aging cell,2023,22(1):e13743.
[27] Lai Y,He J,Gao X,et al. Involvement of plasminogen activator inhibitor-1 in p300/p53-mediated age-related atrial fibrosis[J]. PeerJ,2023,11:e16545.
[28] Li Q,Lai Y,Gao X,et al. Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation[J]. PeerJ,2021,9:e11488.
[29] Datta Chaudhuri R,Datta R,Rana S,et al. Cardiomyocyte-specific regression of nitrosative stress-mediated S-Nitrosylation of IKKγ alleviates pathological cardiac hypertrophy[J]. Cell Signal,2022,98:110403.
[30] Fan M,Yang K,Wang X,et al. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction[J]. Sci Adv,2023,9(5):eadc9465.
[31] Fang Z,Wang X,Sun X,et al. The role of histone protein acetylation in regulating endothelial function[J]. Front Cell Dev Biol,2021,9:672447.
[32] Funamoto M,Sunagawa Y,Katanasaka Y,et al. Histone acetylation domains are differentially induced during development of heart failure in Dahl salt-sensitive rats[J]. Int J Mol Sci,2021,22(4):1771.
[33] Vlad ML,Manea SA,Lazar AG,et al. Histone acetyltransferase-dependent pathways mediate upregulation of NADPH oxidase 5 in human macrophages under inflammatory conditions:a potential mechanism of reactive oxygen species overproduction in atherosclerosis[J]. Oxid Med Cell Longev,2019,2019:3201062.
[34] Shi J,Wang QH,Wei X,et al. Histone acetyltransferase P300 deficiency promotes ferroptosis of vascular smooth muscle cells by activating the HIF-1α/HMOX1 axis[J]. Mol Med,2023,29(1):91.
[35] Kawase Y,Sunagawa Y,Shimizu K,et al. 6-Shogaol,an active component of ginger,inhibits p300 histone acetyltransferase activity and attenuates the development of pressure-overload-induced heart failure[J]. Nutrients,2023,15(9):2232.
[36] Strachowska M,Robaszkiewicz A. Characteristics of anticancer activity of CBP/p300 inhibitors—Features of their classes,intracellular targets and future perspectives of their application in cancer treatment[J]. Pharmacol Ther,2024,257:108636.
[37] He ZX,Wei BF,Zhang X,et al. Current development of CBP/p300 inhibitors in the last decade[J]. Eur J Med Chem,2021,209:112861.
[38] Sunagawa Y,Tsukabe R,Irokawa Y,et al. Anserine,a histidine-containing dipeptide,suppresses pressure overload-induced systolic dysfunction by inhibiting histone acetyltransferase activity of p300 in mice[J]. Int J Mol Sci,2024,25(4):2344.
[39] Funamoto M,Sunagawa Y,Katanasaka Y,et al. Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD[J]. Int J Chron Obstruct Pulmon Dis,2016,11:2029-2034.
[40] Shimizu K,Sunagawa Y,Funamoto M,et al. The synthetic curcumin analogue GO-Y030 effectively suppresses the development of pressure overload-induced heart failure in mice[J]. Sci Rep,2020,10(1):7172.
[41] Bapat P,Ghadi R,Chaudhari D,et al. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin[J]. Int J Pharm,2019,560:219-227.
[42] Zorro Shahidian L,Haas M,Le Gras S,et al. Succinylation of H3K122 destabilizes nucleosomes and enhances transcription[J]. EMBO Rep,2021,22(3):e51009.